Type 2 Diabetes Mellitus With Diabetic Nephropathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Type 2 Diabetes Mellitus With Diabetic Nephropathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Type 2 Diabetes Mellitus With Diabetic Nephropathy trials you may qualify forThe overarching goal of this study is to understand facilitators and barriers to self-care, develop and refine a culturally tailored intervention to improve cli…
This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidne…
This study will evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses (SAD) and multiple ascending doses (MA…
Diabetes mellitus
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein int…
The goal of this clinical trial is to evaluate the safety and efficacy of a single intra-renal injection of allogeneic umbilical cord-derived mesenchymal stem c…
SGLT2 inhibitors such as ertugliflozin improve blood pressure and kidney outcomes in people living with diabetes through incompletely understood mechanisms, how…
To evaluate the efficacy and safety of CU01-1001 administered for 24 weeks in type 2 diabetic nephropathy patients with albuminuria.